When Experiments Travel (eBook)

Clinical Trials and the Global Search for Human Subjects

Adriana Petryna (Autor)

eBook Download: PDF | EPUB

2009
272 Seiten
Princeton University Press (Verlag)
978-1-4008-3082-4 (ISBN)

Infos

Adriana Petryna is associate professor of anthropology at the University of Pennsylvania. She is the author of the award-winning Life Exposed: Biological Citizens after Chernobyl (Princeton) and the coeditor of Global Pharmaceuticals: Ethics, Markets, Practices.

---

The phenomenal growth of global pharmaceutical sales and the quest for innovation are driving an unprecedented search for human test subjects, particularly in middle- and low-income countries. Our hope for medical progress increasingly depends on the willingness of the world's poor to participate in clinical drug trials. While these experiments often provide those in need with vital and previously unattainable medical resources, the outsourcing and offshoring of trials also create new problems. In this groundbreaking book, anthropologist Adriana Petryna takes us deep into the clinical trials industry as it brings together players separated by vast economic and cultural differences. Moving between corporate and scientific offices in the United States and research and public health sites in Poland and Brazil, When Experiments Travel documents the complex ways that commercial medical science, with all its benefits and risks, is being integrated into local health systems and emerging drug markets. Providing a unique perspective on globalized clinical trials, When Experiments Travel raises central questions: Are such trials exploitative or are they social goods? How are experiments controlled and how is drug safety ensured? And do these experiments help or harm public health in the countries where they are conducted? Empirically rich and theoretically innovative, the book shows that neither the language of coercion nor that of rational choice fully captures the range of situations and value systems at work in medical experiments today. When Experiments Travel challenges conventional understandings of the ethics and politics of transnational science and changes the way we think about global medicine and the new infrastructures of our lives.

Produkt-Details

• Erscheint lt. Verlag: 27.4.2009
• Verlagsort: Princeton
• Sprache: englisch
• Themenwelt: Medizin / Pharmazie ► Allgemeines / Lexika
• Themenwelt: Medizin / Pharmazie ► Medizinische Fachgebiete ► Medizinethik
• Themenwelt: Studium ► Querschnittsbereiche ► Geschichte / Ethik der Medizin
• Themenwelt: Naturwissenschaften ► Biologie ► Humanbiologie
• Themenwelt: Sozialwissenschaften ► Ethnologie
• Themenwelt: Sozialwissenschaften ► Pädagogik
• Themenwelt: Sozialwissenschaften ► Politik / Verwaltung
• Themenwelt: Sozialwissenschaften ► Soziologie
• Schlagworte: Accountability • Adverse effect • Adverse Event • Antidepressant • Asthma • Bioethics • Biotechnology • Business Model • Calculation • Cardiology • Cardiovascular Disease • caregiver • chronic condition • Clinical Pharmacology • clinical research • clinical study • clinical trial • ClinicalTrials.gov • Clinical trials registry • Clinician • Community health center • Comparative Advantage • Compliance (medicine) • Contract research organization • COX-2 Inhibitor • Disease • drug development • drug industry • efficacy • Enzyme replacement therapy • Experiment • Funding • Global Health • Globalization • Good Clinical Practice • Guideline • Harvard University • Health Care • health equity • health policy • health professional • Health system • Health Technology • Health Technology Assessment • Hospital • human subject research • Imiglucerase • inclusion and exclusion criteria • Indication (medicine) • Informed Consent • Infrastructure • Institution • institutional review board • Internal Medicine • Investigational New Drug • Major trauma • Marketing • Medical degree • Medical Device • Medical Research • medical school • modus operandi • National Institutes of Health • New drug application • Nonsteroidal anti-inflammatory drug • Offshoring • Oncology • Outsourcing • Oxford University Press • patient safety • Pfizer • pharmaceutical drug • Pharmaceutical Industry • pharmacology • Phases of clinical research • Physician • Placebo • prescription drug • Pricing • Privatization • Public Health • Public hospital • Regulation • Regulatory Affairs • Regulatory Agency • Requirement • Research and Development • Right To Health • Rofecoxib • Scientist • Specialty (medicine) • Symptom • Technology • Thalidomide • Triage • Uncertainty • United States Department of Health and Human Services • universal health care • University of California Press • World Health Organization
• ISBN-10: 1-4008-3082-6 / 1400830826
• ISBN-13: 978-1-4008-3082-4 / 9781400830824